|
BCG VACCINE(FREEZE DRIED)
-
|
PARENTERAL ORDINARY DRY VIALS
1-33*100000 C.F.U/0.1ML
|
Uganda
|
NDA/MAL/HDP/0472
|
Registered
|
|
CYVAC 2 Dose
R21 Malaria Antigen 5mcg mcg
|
Solution for injection
|
Tanzania
|
TAN 24 V 0132
|
Registered/Compliant
|
|
DIPTHERIA TOXOID+TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE
-
|
PARENTERAL ORDINARY AMPOULES
>25LF(>30IU) +>5LF(>40IU) ADSORBED ON ?1.5MG
|
Uganda
|
NDA/MAL/HDP/2333
|
Registered
|
|
DIPTHERIA TOXOID+TETANUS TOXOID+B.PERTUSIS ADSORBED ON ALUMINIUM PHOSPATE
-
|
PARENTERAL ORDINARY VIALS
>25LF(>30IU) +>5LF(>40IU) +<16OU(>4PU) ADSORBED ON ?1.5MG
|
Uganda
|
NDA/MAL/HDP/2283
|
Registered
|
|
DTPHH
Adsorbed on Aluminium Phosphate, Al+++ ≤ 1.25 mg/0.5ml,B. pertussis (whole cell) ≤ 16 OU (≥ 4 IU) IOU,Bulk Purified Tetanus Toxoid ≥ 2.5 Lf (≥ 40 IU) LF,Diphtheria Toxoid ≤ 25 Lf (≥ 30 IU) LF,Purified HBsAg ≥ 10 mcg/0.5ml,Purified capsular Hib Polysaccharide (PRP) Conjugated to Tetanus Toxoid (carrier protein) 10 mcg/0.5ml,Thiomersal 0.005 %
|
Suspension for injection
|
Tanzania
|
TZ13H210
|
Registered/Compliant
|
|
DTPHH Vaccine
Adsorbed on Aluminium Phosphate, Al+++ ≤ 1.25 mg/0.5ml,B. pertussis (whole cell) ≤ 16 OU (≥ 4 IU) IOU,Diphtheria Toxoid ≤ 25 Lf (≥ 30 IU) LF,Purified HBsAg ≥ 10 mcg/0.5ml,Purified Tetanus Toxoid ≥ 2.5 Lf (≥ 40 IU) Lf/0.5ml,Purified capsular Hib Polysaccharide (PRP) Conjugated to Tetanus Toxoid (carrier protein) 10 mcg/0.5ml,Thiomersal 0.005 %
|
Suspension for injection
|
Tanzania
|
TZ13H211
|
Registered/Compliant
|
|
ERYTHROPOIETIN
-
|
PARENTERAL ORDINARY PRE-FILLED SYRINGES
5000IU/ 0.5ML
|
Uganda
|
NDA/MAL/HDP/8097
|
Registered
|
|
HEPATITIS B VACCINE(RDNA) ADULT
-
|
PARENTERAL ORDINARY I M VIALS
20MCG/ML
|
Uganda
|
NDA/MAL/HDP/2348
|
Registered
|
|
Hepatitis B Vaccine r-DNA, Adult
Hepatitis B Surface Antigen Aqueous 20 mcg/ml
|
Suspension for injection
20
|
Tanzania
|
TAN 05,684 J07A SER
|
Registered/Compliant
|
|
LIVE ATTENUATED BOVINE HUMAN ROTAVIRUS REASSORTANT STRATIN [G1, G2, G3, G4 AND G9]
-
|
ORAL LIQUID ORDINARY DROPS
? 10^5.6 FFU /SEROTYPE PER DOSE (2.0 ML)
|
Uganda
|
NDA/MAL/HDP/11424
|
Registered
|
|
MEASLES VIRUS
-
|
PARENTERAL ORDINARY DRY VIALS
NOT LESS THAN 1000CCID50/ DOSE
|
Uganda
|
NDA/MAL/HDP/2073
|
Registered
|
|
MEASLES VIRUS+MUMPS VIRUS+RUBELLA VIRUS
-
|
PARENTERAL ORDINARY DRY VIALS
NLT 1000 CCID50+NLT 5000 CCID50 +NLT1000 CCID50
|
Uganda
|
NDA/MAL/HDP/2334
|
Registered
|
|
Measles & Rubella Virus Vaccine Live U.S.P 10 doses
Anhydrous Disodium hydrogen Phosphate g/g,Disodium Edetate g/g,L - Arginine Hydrochloride g/g,Lactalbumin hydrolysate g/g,Measles Virus mg/4ml,Measles Virus 1x10000 mg/4ml,Minimum Essensial Medium (MEM) g/g,Mumps Virus 12.5 x 10000 mg/4ml,Rubella Virus mg/4ml,Rubella Virus 1 x 10000 mg/4ml,Tricine g/g
|
Injection
|
Tanzania
|
TZ14H019
|
Registered/Compliant
|
|
RECOMBINANT HUMAN ERYTHROPOIETIN
-
|
PARENTERAL ORDINARY PRE-FILLED SYRINGES
4000 I.U/1ML
|
Uganda
|
NDA/MAL/HDP/1041
|
Registered
|
|
RECOMBINANT HUMAN ERYTHROPOIETIN
-
|
PARENTERAL ORDINARY PRE-FILLED SYRINGES
2000 I.U/0.5ML
|
Uganda
|
NDA/MAL/HDP/3818
|
Registered
|
|
TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE
-
|
PARENTERAL ORDINARY AMPOULES
?5 LF (?40 IU) ON ?1.25 MG OF ALUMINIUM PHOSPHATE
|
Uganda
|
NDA/MAL/HDP/4652
|
Registered
|